Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

August 10, 2026

Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm intends to reduce promoter stake by generating ₹740 crore via an offer for sale. With six manufacturing sites worldwide, the company caters to over ninety nations and has seen substantial revenue growth attributed to its tuberculosis diagnostic test kits.

More To Explore

Wendy’s draws buyout bid as beef costs and burger rivalry weigh on business

Wendy’s shares jump after Nelson Peltz’s Trian Fund Management offers $7.35 per share to take the burger chain private, as the company faces high beef

October 28, 2026

Bandhan Bank Q2 profit jumps 5.6 times as asset quality improves

Bandhan Bank reported a five-fold rise in Q2 profit to Rs 622 crore, supported by lower provisions and improving asset quality. Net interest income grew

October 28, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003